Stati Uniti - Ingliż - NLM (National Library of Medicine)

epic pharma, llc - bupropion hydrochloride (unii: zg7e5poy8o) (bupropion - unii:01zg3tpx31) - bupropion hydrochloride 150 mg - bupropion hydrochloride extended-release tablets (xl) are indicated for the treatment of major depressive disorder (mdd), as defined by the diagnostic and statistical manual (dsm). the efficacy of the immediate-release formulation of bupropion was established in two 4-week controlled inpatient trials and one 6-week controlled outpatient trial of adult patients with mdd. the efficacy of the sustained-release formulation of bupropion in the maintenance treatment of mdd was established in a long-term (up to 44 weeks), placebo-controlled trial in patients who had responded to bupropion in an 8-week study of acute treatment [see clinical studies (14.1) ]. bupropion hydrochloride extended-release tablets (xl) are indicated for the prevention of seasonal major depressive episodes in patients with a diagnosis of seasonal affective disorder (sad). the efficacy of bupropion hydrochloride extended-release tablets in the prevention of seasonal major depressive episodes was established in 3 placebo-controlled trials in ad

Stati Uniti - Ingliż - NLM (National Library of Medicine)

lupin pharmaceuticals, inc. - bupropion hydrochloride (unii: zg7e5poy8o) (bupropion - unii:01zg3tpx31) - bupropion hydrochloride 150 mg - bupropion hydrochloride extended-release tablets (xl) are indicated for the treatment of major depressive disorder (mdd), as defined by the diagnostic and statistical manual (dsm). the efficacy of the immediate-release formulation of bupropion was established in two 4-week controlled inpatient trials and one 6-week controlled outpatient trial of adult patients with mdd. the efficacy of the sustained-release formulation of bupropion in the maintenance treatment of mdd was established in a long-term (up to 44 weeks), placebo-controlled trial in patients who had responded to bupropion in an 8-week study of acute treatment [see clinical studies (14.1)]. bupropion hydrochloride extended-release tablets (xl) are indicated for the prevention of seasonal major depressive episodes in patients with a diagnosis of seasonal affective disorder (sad). the efficacy of bupropion hydrochloride extended-release tablets (xl) in the prevention of seasonal major depressive episodes was established in 3 placebo-controlled trials i

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

b braun australia pty ltd - sodium chloride, quantity: 0.45 g - injection, solution - excipient ingredients: water for injections - the solutions are indicated for intravenous fluid therapy designed to correct deficiencies in hydration, electrolyte and energy levels. the solutions may also be used as solvents for intravenously administered drugs where compatibility has been established. 0.9% sodium chloride injection may also be used for irrigation of wounds and moistening of wound dressings. compound sodium lactate solution is particularly suitable for the replacement of extracellular fluid loss where isotonic dehydration is evident and in burn therapy.

Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

fresenius kabi deutschland gmbh - sodium chloride - solvent for parenteral use - 0.9 %v/w - electrolyte solutions; sodium chloride

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - potassium chloride, quantity: 2.24 g/l; sodium chloride, quantity: 9 g/l - injection, solution - excipient ingredients: hydrochloric acid; water for injections - the baxter potassium chloride and sodium chloride intravenous infusion is indicated as a source of water and to restore electrolyte balance as required by the patient's clinical condition, such as hypokalaemia.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - potassium chloride, quantity: 1.5 g/l; sodium chloride, quantity: 9 g/l - injection, solution - excipient ingredients: hydrochloric acid; water for injections - the baxter potassium chloride and sodium chloride intravenous infusion is indicated as a source of water and to restore electrolyte balance as required by the patient's clinical condition, such as hypokalaemia.

Stati Uniti - Ingliż - NLM (National Library of Medicine)

b. braun medical inc. - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698) - this intravenous solution is indicated for use in adults and pediatric patients as a source of electrolytes and water for hydration. 0.9% sodium chloride injection usp is indicated for extracellular fluid replacement, treatment of metabolic alkalosis in the presence of fluid loss and mild sodium depletion. 0.9% sodium chloride injection usp is also indicated for use as a priming solution in hemodialysis procedures and may be used to initiate and terminate blood transfusions without hemolyzing red blood cells. sodium chloride injection usp is also indicated as a pharmaceutic aid and diluent for the infusion of compatible drug additives. refer to prescribing information accompanying additive drugs. this solution is contraindicated where the administration of sodium or chloride could be clinically detrimental. directions for use of plastic container caution: do not use plastic container in series connection. to open check for minute leaks by squeezing solution container firmly. if leaks are found, discard solut

Belġju - Ingliż - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

b. braun melsungen ag - sodium chloride 9 mg/ml; glucose monohydrate 55 mg/ml - eq. glucose anhydrous 50 g/l - solution for infusion - glucose monohydrate 55 mg/ml; sodium chloride 9 mg/ml - electrolytes with carbohydrates

Belġju - Ingliż - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

b. braun melsungen ag - potassium chloride 0,4 mg/ml; sodium chloride 6 mg/ml; sodium lactate 3,12 mg/ml; calcium chloride dihydrate 0,27 g/1000 ml - solution for infusion - potassium chloride 0.4 mg/ml; sodium lactate 3.12 mg/ml; sodium chloride 6 mg/ml; calcium chloride dihydrate - electrolytes

Belġju - Ingliż - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

b. braun melsungen ag - sodium chloride 0,9 g/100 ml - solution for infusion - sodium chloride 9 mg/ml - electrolytes